Latest News

Friday, June 23, 2017 | Product Releases

New Screen Coating Makes Reading in Sunlight a Lot Easier. The Secret? Moth Eyes

Screens on even the newest phones and tablets can be hard to read outside in bright sunlight. Inspired by the nanostructures found on moth eyes, researchers have developed a new antireflection film th…

Read the full story

Friday, June 23, 2017 | Health Care

Senate Republicans Unveil Bill to Repeal Affordable Healthcare Act

Republican party leaders in the US Senate unveiled their health care reform bill on Thursday, ahead of a possible vote next week. The legislation follows a version passed in the House of Representativ…

Read the full story

Friday, June 23, 2017 | Management/Leadership, Ocular Therapeutix

Ocular Therapeutix Announces Executive Transition Plans

Ocular Therapeutix announced that in line with Ocular’s strategic plan and growth objectives, Antony Mattessich will succeed Amar Sawhney, PhD, as Chief Executive Officer, on or before September…

Read the full story

Friday, June 23, 2017 | Product Releases

RightEye Launches Maze Master Eye-Tracking Game Designed to Improve Reading Skills

RightEye announced the launch of RightEye Maze Master, a computer game that helps users gain better control over movement of one or both of their eyes. Maze Master works in conjunction with the RightE…

Read the full story

Thursday, June 22, 2017 | Product Releases

EyeCare Prime Introduces Prime Nexus Patient Relationship Management System

To foster more effective patient engagement and help drive practice growth, EyeCare Prime has unveiled Prime Nexus, a next-generation, cloud-based patient relationship management system. The Prime Nex…

Read the full story

Thursday, June 22, 2017 | Product Releases, Topcon Medical Systems

Topcon Medical Systems Announces Launch of Research Foundation

Topcon Medical Systems has established the Topcon Research Foundation, which will provide support for studies sponsored by independent investigators and institutions that utilize Topcon products to ad…

Read the full story

Thursday, June 22, 2017 | Clinical Trials

Nemus Bioscience Reports on Impact of NB1111 on Tissues that Regulate IOP in an Animal Normotensive Ocular Model

Nemus Bioscience announced that tetrahydrocannabinol (THC) derived from NB1111, the proprietary Nemus prodrug of THC, achieved significant tissue concentrations in multiple compartments of the eye tha…

Read the full story

Thursday, June 22, 2017 | Retina, Psivida

pSivida Submits Marketing Authorization Application for Approval of Durasert 3-Year Treatment for Posterior Segment Uveitis in the EU

pSivida Corp. has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA), seeking approval to market the company’s Durasert 3-year treatment for posterior s…

Read the full story

Thursday, June 22, 2017 | Clinical Trials, Retina

RXi Pharmaceuticals Announces Completion of Enrollment of Phase 1/2 Clinical Trial with RXI-109 for Retinal Scarring

RXi Pharmaceuticals announced the completion of enrollment in its phase 1/2 study RXI-109-1501. This multicenter, multidose, dose escalation trial is being conducted in patients with advanced neovascu…

Read the full story

Wednesday, June 21, 2017 | Product Releases, Retina, Bausch+Lomb

Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry’s Meeting

Bausch + Lomb announced the launch of a new virtual reality tool using state-of-the-art technology. The Age-Related Macular Degeneration (AMD) Virtual Experience, unveiled during the annual meeting of…

Read the full story

Wednesday, June 21, 2017 | Clinical Trials, Glaucoma, Glaukos Corporation

Study: Combining Implantation of Glaukos iStent inject with Topical Travoprost Provides Sustained IOP Reduction and Favorable Safety Profile

Glaukos announced that a study of 53 open-angle glaucoma subjects recently published in Clinical & Experimental Ophthalmology showed that the iStent inject Trabecular Micro-Bypass, combined with t…

Read the full story

Wednesday, June 21, 2017 | Medical Studies

International Academy of Low Vision Specialists Recognizes the Mental Health Changes That May Come with a Diagnosis of AMD

The diagnosis of low vision due to age, such as macular degeneration, often comes with more consequences than just the inability to see. A new study by the National Eye Institute (NEI) reports that pa…

Read the full story

Wednesday, June 21, 2017 | Product Releases, Johnson & Johnson Vision Care

Johnson & Johnson Vision Champions Eye Health Advocates Through New Advocacy Academy

Johnson & Johnson Vision Care announced the launch of Advocacy Academy, an on-demand virtual learning tool to educate, empower and mobilize a new community of eye health advocates to engage with l…

Read the full story

Tuesday, June 20, 2017 | Awards

Surgilūm Announces Recipients of "Surgilūm Award of Excellence" to Outstanding Graduating Residents

Surgilūm announced the recipients of the first "Surgilūm Award of Excellence" to Jithin Yohannan, MD, of the Wilmer Eye Institute; Albert S. Hazan, MD, of Columbia University Medical Cente…

Read the full story

Tuesday, June 20, 2017 | Clinical Trials, Novartis

Novartis RTH258 (Brolucizumab) Demonstrates Robust Visual Gains in Wet AMD Patients with a Majority on a 12-week Injection Interval

Novartis reported that RTH258 (brolucizumab) 6 mg met the primary and key secondary endpoints in two phase 3 studies, HAWK and HARRIER. RTH258 3 mg, evaluated in HAWK, also met these endpoints. These …

Read the full story
Load More